Report ID |
103222 |
Drug Identification Number |
02473968 |
Brand name |
ODAN-SODIUM POLYSTYRENE SULFONATE |
Common or Proper name |
Sodium Polystyrene Sulfonate Oral/Rectal Suspension |
Company Name |
ODAN LABORATORIES LTD |
Market Status |
MARKETED |
Active Ingredient(s) |
SODIUM POLYSTYRENE SULFONATE |
Strength(s) |
250MG |
Dosage form(s) |
SUSPENSION |
Route of administration |
ORAL
RECTAL |
Packaging size |
60 mL |
ATC code |
V03AE |
ATC description |
ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage |
Other (Please describe in comments) |
Anticipated start date |
2020-01-13 |
Actual start date |
2020-01-13 |
Estimated end date |
2022-01-30 |
Actual end date |
2022-06-02 |
Shortage status |
Resolved |
Updated date |
2022-06-07 |
Company comments |
Delay in testing of the drug |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
info@odanlab.com
Tel.: 1-800-387-9342
Fax: 1-800-329-6326 |